S1PR modulators possess a unique mechanism of action in the treatment of multiple sclerosis (MS). Subtype 1 of the S1PR is expressed on the surface of lymphocytes and is important in regulating egression from lymph nodes. The S1PR modulators indirectly antagonize the receptor's function leading to sequestration of lymphocytes in the lymph nodes.
This report contains market size and forecasts of Sphingosine 1-Phosphate Receptor (S1PR) Modulator in Global, including the following market information:
Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sphingosine 1-Phosphate Receptor (S1PR) Modulator market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
S1P1 Subtype Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sphingosine 1-Phosphate Receptor (S1PR) Modulator include Novartis Pharmaceutical Corporation, Bristol-MyersSquibbCompany, JNJ (Janssen), Celgene, Merck and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sphingosine 1-Phosphate Receptor (S1PR) Modulator companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market Segment Percentages, by Type, 2021 (%)
S1P1 Subtype
S1P5 Subtype
Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market Segment Percentages, by Application, 2021 (%)
RMS Treatment for Adult
Relive RMS Clininal Symptoms
Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sphingosine 1-Phosphate Receptor (S1PR) Modulator Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sphingosine 1-Phosphate Receptor (S1PR) Modulator revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sphingosine 1-Phosphate Receptor (S1PR) Modulator revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis Pharmaceutical Corporation
Bristol-MyersSquibbCompany
JNJ (Janssen)
Celgene
Merck
Biogen